Advanced search
Publication Cover
Journal of Liposome Research Volume 12, 2002 - Issue 1-2
Submit an article Journal homepage
49
Views
15
CrossRef citations to date
0
Altmetric
Research Article

A NEW COLLOIDAL LIPIDIC SYSTEM FOR GENE THERAPY

A. Fahr Department of Pharmaceutical Technology, University of Jena, Lessingstraße 8, Jena, D-07743, Germany
,
K. Müller Schering AG, Berlin, Germany
,
Th. Nahde Vectron Therapeutics AG, Emil-Mannkopff-Strasse 2, Marburg, 35037, Germany
,
Rolf Müller Vectron Therapeutics AG, Emil-Mannkopff-Strasse 2, Marburg, 35037, Germany
&
Sabine Brüsselbach Vectron Therapeutics AG, Emil-Mannkopff-Strasse 2, Marburg, 35037, Germany
Pages 37-44 | Published online: 15 Jul 2002

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Jeffrey A. Nemeth, Marian T. Nakada, M. Trikha, Zhihui Lang, Michael S. Gordon, Gordon C. Jayson, Robert Corringham, Uma Prabhakar, Hugh M. Davis & Robert A. Beckman. (2007) Alpha-v Integrins as Therapeutic Targets in Oncology. Cancer Investigation 25:7, pages 632-646.
Read now
Sérgio Simões, Ana Filipe, Henrique Faneca, Miguel Mano, Nuno Penacho, Nejat Düzgünes & Maria Pedroso de Lima. (2005) Cationic liposomes for gene delivery. Expert Opinion on Drug Delivery 2:2, pages 237-254.
Read now
M. R. Mozafari, C. J. Reed, C. Rostron & V. Hasirci. (2005) A Review of Scanning Probe Microscopy Investigations of Liposome-DNA Complexes. Journal of Liposome Research 15:1-2, pages 93-107.
Read now
Mohsen M. Mady, M.M. Ghannam, W.A. Khalil, R. Repp, M. Markus, W. Rascher, R. Müller & Alfred Fahr. (2004) Efficient Gene Delivery with Serum into Human Cancer Cells Using Targeted Anionic Liposomes. Journal of Drug Targeting 12:1, pages 11-18.
Read now

Articles from other publishers (11)

. 2016. Bio-Targets and Drug Delivery Approaches. Bio-Targets and Drug Delivery Approaches 1 23 .
Yahya E. Choonara, Viness Pillay, Valence M.K. Ndesendo, Lisa C. du Toit, Pradeep Kumar, Riaz A. Khan, Caragh S. Murphy & Debbie-Leigh Jarvis. (2011) Polymeric emulsion and crosslink-mediated synthesis of super-stable nanoparticles as sustained-release anti-tuberculosis drug carriers. Colloids and Surfaces B: Biointerfaces 87:2, pages 243-254.
Crossref
Dagmar Fischer & Alfred Fahr. (2011) Nichtvirale Gentransfer‐Arzneimittel. Therapie mit synthetischen Vektoren. Pharmazie in unserer Zeit 40:3, pages 212-219.
Crossref
Todd O. Pangburn, Matthew A. Petersen, Brett Waybrant, Maroof M. Adil & Efrosini Kokkoli. (2009) Peptide- and Aptamer-Functionalized Nanovectors for Targeted Delivery of Therapeutics. Journal of Biomechanical Engineering 131:7.
Crossref
Mohsen M. Mady, M.M. Ghannam, W.A. Khalil, R. Müller & Alfred Fahr. (2009) Efficiency of cytoplasmic delivery by non-cationic liposomes to cells in vitro: A confocal laser scanning microscopy study. Physica Medica 25:2, pages 88-93.
Crossref
Benedetta Bussolati, Cristina Grange, Lorenzo Tei, Maria Chiara Deregibus, Mauro Ercolani, Silvio Aime & Giovanni Camussi. (2007) Targeting of human renal tumor-derived endothelial cells with peptides obtained by phage display. Journal of Molecular Medicine 85:8, pages 897-906.
Crossref
P Dubey, S Vyas & S Mahor. 2006. Nanotechnology for Cancer Therapy. Nanotechnology for Cancer Therapy 643 661 .
Michelle L. Flenniken, Deborah A. Willits, Ann L. Harmsen, Lars O. Liepold, Allen G. Harmsen, Mark J. Young & Trevor Douglas. (2006) Melanoma and Lymphocyte Cell-Specific Targeting Incorporated into a Heat Shock Protein Cage Architecture. Chemistry & Biology 13:2, pages 161-170.
Crossref
Paulina Wyrozumska, Katarzyna Stebelska, Michal Grzybek & Aleksander F. Sikorski. 2006. Nanocarrier Technologies. Nanocarrier Technologies 139 174 .
Kai Temming, Raymond M. Schiffelers, Grietje Molema & Robbert J. Kok. (2005) RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature. Drug Resistance Updates 8:6, pages 381-402.
Crossref
Mohsen Shadidi & Mouldy Sioud. (2003) Selective targeting of cancer cells using synthetic peptides. Drug Resistance Updates 6:6, pages 363-371.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.